Mylan Launches Advair Rival In Canada
Firm’s Wixela Inhub Version Is First Rival To GSK Brand
Mylan has rolled out the first generic rival to GlaxoSmithKline’s Advair in Canada with the launch of its Wixela Inhub version.
Mylan has rolled out the first generic rival to GlaxoSmithKline’s Advair in Canada with the launch of its Wixela Inhub version.